Finding your next opportunity shouldn’t require piecing together multiple databases, alerts and research tools.
Fundz combines its own funding and M&A intelligence with hiring, leadership and other business signals into one connected view of each company, ranks opportunities against your ideal customer profile, and delivers the evidence and verified contacts to act on. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
uniQure N.V.
The company shared information publicly (Regulation FD). An 8-K is the notice a US public company must file within four business days of a major event.
www.uniqure.comAI Executive Summary
AI-powered analysis of 8-K filing content
uniQure N.V. provided a clinical update on its AMT-130 program on September 29, 2026, sharing advancements in ongoing clinical trials through a presentation and press release. This disclosure informs stakeholders of R&D progress that may influence investor perception and stock valuation.
Key Takeaways
uniQure presented significant advancements in AMT-130 clinical development on September 29, 2026
The update was disseminated via both presentation and press release to inform shareholders and the market
2 more takeaways
Filing Overview
What This Means
uniQure N.V. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.